In The News
CenterWatch | OCTOBER 14, 2016
We've partnered with ImmunoAssay, a molecular diagnostics company advancing the development of novel, multi-marker tests for complex diseases with compelling levels of accuracy, to help continue our work in neurology and further develop their portfolio for clinical utility.
Clinical Lab Products | December 13, 2016
Quanterix Corp, Lexington, Mass, will join forces with UmanDiagnostics AB, Umeå, Sweden, to provide commercial access to an ultrasensitive single molecule array (Simoa) assay for the detection of neurofilament light (Nf-light) in blood specimens.
NPR Science Friday | January 13, 2017
NPR Science Friday segment featuring guests Jessica Gill and Robert Stern discussing new research that finds that levels of tau in the blood after a concussion correlate with how long it takes an athlete to return to play.
Boston Globe | February 6, 2017
Malden Catholic athletic trainer Torey Manzi administers a concussion check during a Malden-Xaverian football game in 2012.
Scientific American | March 9, 2017
Physicians need more than the question: “How many fingers am I holding up?”
Clinical Lab Products | May 2017
Our ultra-sensitive Simoa platform and complete assay kits were featured in this month’s issue of Clinical Lab Products magazine. View our listing on page 26
DDN News | August 2017
The study, entitled “Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury,” is a proof-of-concept paper showing how the scientists combined Quanterix’s Single Molecule Array Detection technology, or Simoa, and…
The Guardian| October 30, 2017
Several firms trying to develop new methods to assess extent of damage
December 11, 2015
New Concussion Test Could Be A Medical Breakthrough